Skip to main content

Table 5 Type of treatment of all studied patients

From: Role of PET/CT in patients with unexplained rising alpha fetoprotein post HCC interventional management

Type of treatment

All studied patients (n = 40)

No.

%

RFA

10

25%

MWA

5

12.5%

TACE

15

37.5%

Combined

10

25%